TickerFacts.

Company research / INGN

Inogen Inc (INGN)

Build a valuation ↗↓ Download CSV

CIK 0001294133 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Inogen Inc reported revenue of $348.67M. Revenue grew 3.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $354.30M.

Key ratios (year ended 2025-12-31)

44.2%
Gross margin
-8.7%
Operating margin
-6.5%
Net margin
-11.8%
Return on year-end equity
3.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-30

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$354.30M$348.67M$335.70M$315.66M$377.24M$358.00M$308.49M$361.94M$358.11M$249.44M$202.83M
Cost of Revenue$196.62M$194.40M$180.96M$188.96M$223.71M$181.52M$170.31M$190.08M$179.53M$128.20M$105.52M
Gross Profit$157.69M$154.26M$154.74M$126.70M$153.53M$176.48M$138.18M$171.86M$178.58M$121.24M$97.31M
R&D Expense$21.12M$19.40M$21.61M$20.84M$21.94M$16.58M$14.08M$9.40M$7.03M$5.31M$5.11M
Operating Income-$30.85M-$30.21M-$42.52M-$109.39M-$85.24M$9.24M-$12.03M$19.79M$37.89M$27.59M$22.86M
Depreciation & Amortization$19.86M$20.66M$21.00M$18.15M$23.51M$21.63M$18.58M$13.83M$11.29M$12.30M$13.56M
EBITDA-$11.00M-$9.55M-$21.51M-$91.23M-$61.73M$30.87M$6.56M$33.62M$49.19M$39.89M$36.42M
Net Income-$24.59M-$22.75M-$35.89M-$102.45M-$83.77M-$6.33M-$5.83M$20.95M$51.84M$21.00M$20.52M
EPS (Diluted)n/a-$0.86-$1.52-$4.42-$3.67-$0.28-$0.27$0.94$2.30$0.96$0.97
Total Assets$285.57M$298.62M$296.19M$326.19M$405.04M$489.51M$461.85M$447.34M$375.90M$275.07M$214.05M
Total Liabilities$110.71M$106.39M$122.33M$121.38M$107.64M$119.29M$112.23M$102.72M$65.47M$48.03M$31.96M
Shareholders' Equity$174.86M$192.23M$173.86M$204.81M$297.41M$370.23M$349.62M$344.62M$310.42M$227.04M$182.09M
Cash & Equivalents$87.28M$103.73M$113.80M$125.49M$187.01M$235.52M$211.96M$198.04M$196.63M$142.95M$92.85M
Operating Cash Flow-$2.52M-$11.22M$5.91M-$3.23M-$37.53M$23.63M$37.01M$40.59M$59.98M$60.49M$31.03M
Capital Expenditures$2.47M$2.52M$3.36M$5.22M$3.34M$5.48M$4.38M$3.14M$8.04M$2.91M$1.72M
Free Cash Flow-$4.98M-$13.74M$2.55M-$8.45M-$40.87M$18.15M$32.63M$37.45M$51.93M$57.58M$29.32M
Shares Outstanding26.73M27.23M23.90M23.32M22.94M22.73M22.13M22.03M21.78M20.98M20.39M
Weighted Average Diluted Sharesn/a26.60M23.65M23.18M22.85M22.49M21.98M22.24M22.51M21.90M21.10M
EPS (Basic)n/a-$0.86-$1.52-$4.42-$3.67-$0.28-$0.27$0.96$2.44$1.02$1.02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView